age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
33.72998
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 35,602
| 24,688.875
| 25,589.0469
| 13
|
black
| 20.898438
| 12
| 0.878906
| 0.835938
| 22
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 9
| 95
| 5
| 104
| 24
| 37.69531
| 253.03125
| 2
| 1.099854
| 0.699951
| 133
| 7.40918
| null | null | null | 4
| 2
|
no(M2 and SIP pres)
| 2
| 1,321
| 0
|
57.71399
|
female
| 0
| 21
|
MOSF w/Malig
|
ARF/MOSF
| 4
| 11
|
under $11k
| 9
| 22,480
| 14,848.2656
| 18,645.4375
| 25
|
black
| 17.398438
| 20
| 0.744995
| 0.665894
| 1
| 1
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 8
| 89
| 40.09375
| 96
| 24
| 39.59375
| 261.875
| 2.599609
| 0.5
| 1.099854
| 141
| 7.489258
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 31
| 1
|
70.40094
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 8
|
$11-$25k
| 0
| 4,826
| 3,220.4199
| 3,311.68945
| 6
|
white
| 15.798828
| 25
| 0.887939
| 0.81189
| 1
| 0
| 0
|
no
| 0.53
| 0.3
|
dnr after sadm
| 2
| 108
| 7.599609
| 74
| 22
| 36.29688
| 380.9375
| 3.599609
| 1
| 1.599854
| 140
| 7.5
| null | null | null | null | null | null | 2.507813
| 307
| 1
|
26.26099
|
male
| 1
| 4
|
Coma
|
Coma
| 4
| null | null | 0
| 11,013
| 7,114.2812
| 7,941.80859
| 70
|
black
| 46
| 68
| 0.473999
| 0.40094
| 1
| 1
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 4
| 41
| 11.699219
| 0
| 46
| 39.09375
| 167.5
| 2.5
| 0.899902
| 1.699951
| 143
| 7.199219
| null | null | null | null | null |
<2 mo. follow-up
| 2.440918
| 4
| 1
|
70.79297
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
|
under $11k
| 0
| 3,689
| 2,464.5469
| 2,637.85938
| 7
|
white
| 13.798828
| 22
| 0.902954
| 0.836914
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 107
| 5.899414
| 53
| 22
| 35.69531
| null | 4.399414
| 0.699951
| 1.399902
| 141
| 7.419922
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 668
| 1
|
63.56998
|
male
| 0
| 44
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 44
| 126,224
| 82,239.625
| 91,960.5
| 42.5
|
white
| 25
| 24
| 0.602905
| 0.495972
| 4
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 44
| 118
| 17.796875
| 136
| 8
| 39.19531
| 190
| 2
| 1.399902
| 1.199951
| 150
| 7.40918
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 227
| 1
|
52.29797
|
male
| 1
| 25
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 0
| 108,667
| 69,016.75
| 82,232.3125
| 57
|
white
| 30.597656
| 53
| 0.537964
| 0.422974
| 2
| 0
| 0
|
yes
| 0.7
| 0.5
|
no dnr
| 25
| 57
| 22.597656
| 136
| 32
| 39.19531
| 131.09375
| 2.399902
| 0.699951
| 1.099854
| 147
| 7.569336
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 25
| 1
|
50.10797
|
female
| 0
| 20
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 13
|
$11-$25k
| 9
| 59,953
| 32,717.1094
| 41,005.7812
| 30.333328
|
white
| 28.597656
| 35
| 0.469971
| 0.35199
| 14
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 20
| 74
| 0
| 101
| 20
| 35.79688
| null | 2.599609
| 0.5
| 0.899902
| 133
| null | null | null | null | 0
| 0
|
SIP>=30
| 0
| 448
| 1
|
40.57999
|
male
| 0
| 61
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 9
| 173,158
| 116,037.625
| 131,353.25
| 54
|
white
| 35.195313
| 66
| 0.637939
| 0.536987
| 4
| 0
| 0
|
no
| 0.05
| 0.000125
|
no dnr
| 61
| 60
| 12
| 132
| 14
| 38.39844
| 108
| 1.699951
| 2.899902
| 4.799805
| 142
| 7.279297
| null | null | null | null | 1
|
SIP>=30
| 1
| 1,316
| 0
|
53.823
|
female
| 0
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 15,461
| 9,543.1797
| 11,886.4141
| 13
|
white
| 25.699219
| 25
| 0.532959
| 0.417969
| 7
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 8
| 89
| 0.699951
| 101
| 20
| 36.69531
| null | null | null | 0.899902
| 135
| null | null | null | null | 1
| 1
| null | 1
| 68
| 1
|
74.22894
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$11-$25k
| 0
| 15,964
| 9,384.25
| 10,116.2891
| 20
|
white
| 24.199219
| 31
| 0.770996
| 0.696899
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 13
| 77
| 9.898438
| 107
| 28
| 36.29688
| 276.625
| 2.5
| 1.699951
| 1.399902
| 131
| 7.479492
| null | null | null | 3
| 6
| null | 6
| 118
| 1
|
76.61096
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null |
under $11k
| 0
| 2,487
| 1,572.0332
| 1,814.7998
| 11
|
black
| 17.699219
| 31
| 0.851929
| 0.755981
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 62
| 5.399414
| 110
| 20
| 36.39844
| 376.1875
| null | 1.199951
| 1.299805
| 138
| 7.529297
| null | null | null | null | null | null | 2.544922
| 160
| 1
|
49.28699
|
male
| 1
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 0
| 86,797
| 55,757.6562
| 64,130.4375
| 45.25
|
white
| 26.5
| 50
| 0.765991
| 0.690918
| 14
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 28
| 115
| 34.09375
| 140
| 28
| 38
| 347.5625
| 2.399902
| 3.399902
| 0.5
| 137
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 3.225098
| 28
| 1
|
69.37994
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 13
| null | 0
| 10,879
| 5,274.4727
| 6,358.31641
| 18
|
white
| 29.699219
| 36
| 0.557983
| 0.362
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.8
|
no dnr
| 7
| 59
| 5.5
| 136
| 22
| 36.59375
| null | 2.5
| 1.5
| 1.199951
| 130
| null | null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 55
| 1
|
70.88599
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 6,045
| 3,868.6758
| 4,133.01953
| 9.5
|
white
| 17.796875
| 17
| 0.861938
| 0.770996
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 7
| 94
| 17.597656
| 118
| 24
| 36.59375
| 280
| 4
| 1
| 1
| 136
| 7.369141
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 793
| 1
|
62.59299
|
male
| 1
| 36
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 7
| 10
|
$11-$25k
| 9
| 119,264
| 76,845
| 88,983.75
| 48.25
|
white
| 25.699219
| 50
| 0.569946
| 0.375
| 5
| 1
| 0
|
no
| 0.7
| 0.6
|
dnr after sadm
| 32
| 120
| 20.5
| 61
| 33
| 36
| 257.125
| 2.199707
| 3.099609
| 1.299805
| 129
| 7.399414
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 36
| 1
|
36.98297
|
male
| 0
| 24
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 26,586
| 17,302.4688
| 18,924.75
| 17
|
black
| 33.59375
| 35
| 0.737915
| 0.588989
| 6
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 24
| 73
| null | 107
| 28
| 35.89844
| 280
| 2.399902
| 2.399902
| 1.299805
| 127
| 7.449219
| null | null | null | 0
| 0
|
SIP>=30
| 0
| 60
| 1
|
52.19199
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 5,321
| 3,410.6738
| 4,506.80859
| 10
|
white
| 18.898438
| 5
| 0.814941
| 0.601929
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
no dnr
| 6
| 86
| 8.5
| 59
| 20
| 36.5
| null | 3.299805
| 1
| 0.799927
| 136
| null | null | null | null | 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 179
| 1
|
70.46997
|
female
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 9
| 94,955
| 62,118.1562
| 68,680.4375
| 38.5
|
white
| 37.5
| 52
| 0.334961
| 0.218994
| 12
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 38
| 50
| 29.296875
| 80
| 10
| 36.39844
| 115.54688
| 1.699951
| 6.899414
| 0.599976
| 135
| 7.429688
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 100
| 1
|
78.80597
|
male
| 1
| 15
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 6
|
under $11k
| 9
| 15,662
| 10,750.6406
| 13,315.3125
| 10.333328
|
black
| 23.296875
| 39
| 0.588989
| 0.47998
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.2
|
dnr after sadm
| 1
| 66
| 17.5
| 71
| 20
| 35.89844
| 523.75
| 2.5
| 1.599854
| 2.299805
| 142
| 7.459961
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 15
| 1
|
71.78894
|
male
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
under $11k
| 26
| 91,348
| 59,310.0625
| 68,936.5625
| 50.25
|
white
| 31.796875
| 38
| 0.511963
| 0.394958
| 1
| 0
| 0
|
no
| 0.4
| 0.4
|
no dnr
| 38
| 82
| 24.199219
| 106
| 15
| 38.09375
| 91.25
| 2.5
| 1.5
| 2.5
| 144
| 7.369141
| null | null | null | null | 6
|
no(M2 and SIP pres)
| 6
| 937
| 1
|
34.875
|
male
| 1
| 14
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 0
|
under $11k
| 0
| 59,218
| 37,512
| 42,662.9375
| 56.666657
|
white
| 44.398438
| 67
| 0.161987
| 0.079987
| 3
| 0
| 0
|
yes
| 0.6
| 0.5
|
no dnr
| 14
| 51
| 2.199707
| 160
| 28
| 35.89844
| 123.75
| 2.299805
| 1.5
| 0.699951
| 132
| 7.419922
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 14
| 1
|
78.97095
|
female
| 0
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 5,415
| 2,838.0508
| 3,703.69922
| 24
|
black
| 19.398438
| 22
| 0.677979
| 0.583984
| 3
| 0
| 0
|
metastatic
| 0.3
| 0.2
|
no dnr
| 4
| 101
| 9.798828
| 76
| 22
| 36.09375
| null | null | null | 1.199951
| 129
| null | null | null | null | 0
| 1
|
<2 mo. follow-up
| 1
| 30
| 1
|
62.74298
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 6
|
under $11k
| 0
| 7,487
| 4,930.6758
| 5,606.25781
| 10
|
black
| 22.097656
| 39
| 0.827881
| 0.768921
| 2
| 1
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 6
| 132
| 11.798828
| 96
| 24
| 36.69531
| 252.375
| null | 0.399963
| 2.399902
| 136
| 7.329102
| null | null | null | 2
| 1
|
SIP>=30
| 1
| 1,302
| 0
|
84.112
|
male
| 0
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
|
under $11k
| 0
| 25,533
| 16,575.125
| 18,047.8594
| 17.75
|
white
| 34.59375
| 59
| 0.481995
| 0.363953
| 1
| 0
| 1
|
no
| 0.5
| 0.4
|
dnr after sadm
| 2
| 61
| 3.199707
| 138
| 36
| 39
| 191.40625
| 2
| 1.099854
| 2.5
| 150
| 7.329102
| null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 274
| 1
|
59.23898
|
female
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 15
|
$25-$50k
| 55
| 5,891
| 3,676.1289
| 4,643.15625
| 13
|
white
| 30.296875
| 32
| 0.156982
| 0.076996
| 3
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 1
| 63
| 19.296875
| 122
| 24
| 37.79688
| null | null | null | 1.699951
| 122
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
53.465
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 5,590
| 3,078.4727
| 3,631.16992
| 12
|
black
| 17.796875
| 27
| 0.907959
| 0.845947
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 4
| 71
| 9.398438
| 71
| 22
| 35.89844
| 152
| 4.199219
| 0.599976
| 1.599854
| 138
| 7.099609
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 225
| 1
|
47.439
|
female
| 0
| 11
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| 14,155
| 9,264.0078
| 11,179.9141
| 15
|
white
| 30.597656
| 37
| 0.682983
| 0.514893
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 11
| 104
| 17.296875
| 113
| 20
| 36.19531
| 566.625
| 2.599609
| 12
| 0.5
| 144
| 7.489258
| null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 323
| 1
|
41.91898
|
male
| 1
| 24
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 16
|
under $11k
| 0
| 49,526
| 31,816.1719
| 39,600.2812
| 21.333328
|
black
| 28.398438
| 43
| 0.763916
| 0.625
| 1
| 0
| 0
|
no
| 0.8
| 0.75
|
dnr after sadm
| 19
| 76
| 3.799805
| 69
| 20
| 36
| null | 1.699951
| 25.296875
| 0.5
| 135
| null | null | null | null | 3
| 4
|
<2 mo. follow-up
| 4
| 24
| 1
|
71.04395
|
female
| 1
| 8
|
Coma
|
Coma
| 3
| 12
|
$25-$50k
| 100
| 39,241
| 25,236.375
| 28,353.5625
| 35
|
white
| 18.097656
| 16
| 0.128998
| 0.081985
| 17
| 0
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 3
| 62
| 10.5
| 65
| 10
| 38.59375
| 346.625
| 2.699707
| 0.299988
| 1.099854
| 166
| 7.399414
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 8
| 1
|
77.55194
|
male
| 1
| 163
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 9
| 265,926
| 177,235.25
| 215,599.375
| 41.5
|
white
| 22.898438
| 51
| 0.75293
| 0.674927
| 1
| 1
| 0
|
no
| 0.8
| 0.8
|
dnr after sadm
| 146
| 155
| 17.898438
| 125
| 28
| 38.89844
| 226.65625
| 2.199707
| 0.799927
| 1.5
| 137
| 7.429688
| null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 163
| 1
|
57.25699
|
male
| 0
| 3
|
Colon Cancer
|
Cancer
| 2
| 7
|
under $11k
| 0
| 2,124
| 1,498.0596
| 1,994.92969
| null |
black
| 9
| 5
| 0.907959
| 0.786987
| 1
| 0
| 0
|
metastatic
| 0.2
| 0
|
dnr after sadm
| 2
| 95
| 10.5
| 58
| 24
| 37.5
| null | null | 0.799927
| 0.799927
| 138
| null | 107
| 6
| 940
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 230
| 1
|
61.84
|
female
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 12,300
| 8,202.9453
| 8,763.98438
| 17
|
black
| 18.199219
| 23
| 0.866943
| 0.778931
| 1
| 0
| 0
|
yes
| 0.9
| 0.89
|
no dnr
| 11
| 65
| 9.5
| 105
| 28
| 38.09375
| 137.5
| null | null | 2
| 137
| 7.419922
| 126
| 29
| 4,955
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,090
| 0
|
67.31
|
female
| 1
| 22
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 0
| 18,881
| 13,809.0859
| 18,162.3125
| 21
|
white
| 26.398438
| 37
| 0.569946
| 0.458984
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 17
| 83
| 5.5
| 100
| 18
| 36.69531
| 274.0625
| null | 0.399963
| 0.699951
| 137
| 7.389648
| 242
| 10
| null | 1
| 2
|
<2 mo. follow-up
| 2
| 22
| 1
|
25.43199
|
female
| 0
| 98
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 277,810
| 175,246.125
| 201,567.375
| 42.25
|
white
| 27
| 45
| 0.880981
| 0.837891
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 98
| 48
| 3.899902
| 115
| 12
| 35.59375
| 388
| 2.599609
| 1.5
| 9.798828
| 126
| 7.449219
| 205
| 56
| 0
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,088
| 0
|
50.19598
|
male
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
under $11k
| 0
| 41,359
| 25,705.0625
| 31,246.625
| 35.5
|
white
| 42.398438
| 83
| 0.48999
| 0.371948
| 1
| 0
| 0
|
no
| 0.4
| 0.35
|
dnr after sadm
| 4
| 83
| 7.799805
| 74
| 24
| 36.79688
| null | 3
| 0.599976
| 0.799927
| 141
| null | 106
| 11
| null | null | 0
|
<2 mo. follow-up
| 0
| 13
| 1
|
77.21295
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null |
under $11k
| 0
| 4,117
| 2,907.9648
| 2,851.25977
| 12
|
white
| 16.898438
| 34
| 0.858887
| 0.767944
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 5
| 121
| 14.599609
| 74
| 20
| 36.09375
| null | 3.599609
| 0.399963
| 0.699951
| 140
| null | 73
| 7
| 2,310
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 434
| 1
|
72.20795
|
female
| 1
| 6
|
Coma
|
Coma
| 1
| 14
|
under $11k
| 100
| 5,676
| 3,781.8262
| 4,726.1875
| 19
|
white
| 26.199219
| 57
| 0.097992
| 0.058998
| 1
| 1
| 0
|
no
| 0.05
| 0.05
|
dnr after sadm
| 1
| 122
| 26.5
| 125
| 8
| 38.09375
| 304
| null | 15.199219
| 8.599609
| 139
| 7.359375
| 166
| 78
| 0
| null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
79.10699
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
| null | 0
| 6,479
| 4,432.9688
| 5,499.58984
| 12
|
white
| 20.296875
| 31
| 0.812988
| 0.695923
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 6
| 68
| 21.699219
| 145
| 25
| 35.5
| 445
| 1.899902
| 0.799927
| 3.799805
| 135
| 7.229492
| 151
| 54
| 1,850
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 403
| 1
|
61.78198
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 30,163
| 17,284.2656
| 20,559.4062
| 23.333328
|
white
| 40.398438
| 53
| 0.404968
| 0.28595
| 4
| 1
| 0
|
no
| 0.05
| 0.01
|
dnr after sadm
| 1
| 63
| 10.599609
| 71
| 28
| 36
| 195
| null | 1.199951
| 1.899902
| 147
| 7.379883
| 106
| 41
| 1,020
| 1
| null | null | 1.166748
| 1,085
| 0
|
51.34299
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 0
|
under $11k
| 0
| 10,785
| 6,678.9844
| 7,258.19922
| 12.5
|
white
| 27.597656
| 22
| 0.845947
| 0.746948
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 9
| 127
| 19.796875
| 120
| 10
| 37.79688
| 171.40625
| null | 0.599976
| 1.199951
| 144
| 7.319336
| 260
| 35
| 1,720
| 0
| null |
SIP>=30
| 0.494751
| 493
| 1
|
79.93994
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 12
| null | 0
| 34,382
| 21,277.8281
| 24,930.6719
| 48.5
|
white
| 36.59375
| 69
| 0.363953
| 0.246979
| 1
| 0
| 1
|
yes
| 0.4
| 0.2
|
dnr after sadm
| 7
| 55
| 14.398438
| 60
| 34
| 38.79688
| 237.125
| 2
| null | 1.099854
| 130
| 7.379883
| 251
| 17
| 480
| null | 7
|
<2 mo. follow-up
| 7
| 10
| 1
|
54.853
|
female
| 1
| 14
|
MOSF w/Malig
|
ARF/MOSF
| 4
| 12
|
>$50k
| 0
| 53,156
| 32,901.25
| 43,947.2188
| 49
|
white
| 28
| 46
| 0.549927
| 0.435974
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.4
|
dnr after sadm
| 11
| 113
| 20.699219
| 75
| 11
| 38.79688
| 290
| null | null | 6.5
| 132
| 7.389648
| 85
| 44
| 230
| null | 2
|
<2 mo. follow-up
| 2
| 14
| 1
|
58.349
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 9
|
under $11k
| 0
| 7,481
| 5,456.5703
| 6,411.69922
| 11.5
|
white
| 16.898438
| 21
| 0.904907
| 0.839966
| 1
| 1
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 9
| 102
| 11.099609
| 125
| 52
| 39.59375
| 152
| null | 0.699951
| 0.699951
| 131
| 7.419922
| 178
| 31
| 770
| 2
| 1
|
no(M2 and SIP pres)
| 1
| 1,080
| 0
|
34.44199
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
| null | 9
| 38,032
| 20,595.1406
| 26,019.5156
| 32.333313
|
white
| 24.898438
| 26
| 0.86499
| 0.817993
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 20
| 65
| 8.699219
| 95
| 29
| 38.39844
| 159.15625
| null | null | 3.5
| 136
| 7.30957
| 151
| 77
| 1,920
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,079
| 0
|
60.64899
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 8
|
$11-$25k
| 0
| 6,610
| 4,424.2109
| 4,562.78906
| 3
|
white
| 17.398438
| 21
| 0.878906
| 0.797974
| 1
| 1
| 0
|
yes
| 0.9
| 0.8
|
no dnr
| 7
| 0
| 12.199219
| 0
| 0
| 36.09375
| 157
| null | null | 0.899902
| 143
| 7.239258
| 141
| 15
| 3,040
| 4
| null |
no(M2 and SIP pres)
| 3.183106
| 92
| 1
|
73.98199
|
male
| 1
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null |
under $11k
| 41
| 9,644
| 6,020.7266
| 6,879.83984
| 66
|
white
| 59.898438
| 85
| 0
| 0
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 53
| 21.296875
| 110
| 36
| 36.19531
| 205
| null | null | 2.199707
| 139
| 7.349609
| 144
| 35
| 425
| null | null |
<2 mo. follow-up
| 3.58252
| 4
| 1
|
43.98898
|
male
| 0
| 14
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 14
|
under $11k
| 0
| 15,008
| 10,454.0859
| 12,681.0234
| 10
|
white
| 27.097656
| 32
| 0.771973
| 0.636963
| 1
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 14
| 102
| 6.5
| 70
| 12
| 38.09375
| 266.625
| null | null | 0.599976
| 135
| 7.459961
| 103
| 7
| 5,570
| 3
| null |
no(M2 and SIP pres)
| 2.510742
| 1,079
| 0
|
34.56799
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 0
| null | 0
| 57,730
| 36,738.7188
| 40,708.375
| 33.666657
|
white
| 14.898438
| 17
| 0.934937
| 0.910889
| 4
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 19
| 113
| 18.398438
| 105
| 35
| 38.59375
| 177.5
| 3.099609
| 1.5
| 0.599976
| 138
| 7.419922
| 86
| 48
| 3,700
| null | 2
|
no(M2 and SIP pres)
| 2
| 1,077
| 0
|
73.08997
|
female
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 26,275
| 16,161.6875
| 22,394.9062
| 55
|
white
| 35.398438
| 83
| 0.385986
| 0.267944
| 1
| 0
| 0
|
yes
| 0.5
| 0.5
|
dnr after sadm
| 5
| 62
| 6.799805
| 65
| 10
| 35
| 596
| 2.899902
| 1.299805
| 0.599976
| 135
| 7.389648
| 183
| 12
| 713
| null | null |
<2 mo. follow-up
| 2.230469
| 5
| 1
|
63.51297
|
male
| 1
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 11
|
under $11k
| 0
| 73,398
| 39,047.5625
| 47,272.9375
| 38.75
|
white
| 21.898438
| 36
| 0.838989
| 0.784912
| 1
| 0
| 0
|
no
| 0.5
| 0.2
|
dnr after sadm
| 25
| 115
| 11
| 65
| 48
| 38.5
| 170
| null | 0.5
| 0.799927
| 131
| 7.40918
| 144
| 16
| 6,820
| null | 0
|
<2 mo. follow-up
| 0
| 25
| 1
|
51.431
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$25-$50k
| 9
| 42,284
| 26,786.9375
| 36,208.5938
| 58
|
white
| 31.898438
| 52
| 0.699951
| 0.609985
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 11
| 113
| 7.599609
| 95
| 16
| 36.29688
| null | null | 1.699951
| 0.599976
| 130
| null | 193
| 25
| null | null | 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
59.34598
|
female
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 11
|
$11-$25k
| 0
| 12,036
| 7,768.1016
| 8,758.36719
| 19.5
|
white
| 22.898438
| 36
| 0.846924
| 0.747925
| 1
| 1
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 11
| 131
| 8.699219
| 55
| 20
| 36.19531
| 253.03125
| null | null | 2.799805
| 144
| 7.389648
| 84
| 49
| 800
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,076
| 0
|
78.448
|
male
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
| null | 26
| 4,403
| 2,999.4981
| 3,697.06836
| 17
|
white
| 27.597656
| 44
| 0.383972
| 0.264954
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr before sadm
| -1
| 96
| 5.399414
| 126
| 24
| 38.29688
| 266.625
| 3.199707
| null | 1.199951
| 142
| 7.439453
| 90
| 44
| 1,350
| null | null |
<2 mo. follow-up
| 4.75293
| 5
| 1
|
52.189
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 5
|
$25-$50k
| 0
| 3,155
| 2,068.5938
| 2,488.80859
| 8
|
white
| 14.599609
| 3
| 0.776978
| 0.535889
| 1
| 0
| 0
|
metastatic
| 1
| 0.6
|
no dnr
| 3
| 74
| 7.699219
| 72
| 20
| 38.5
| null | null | null | 0.799927
| 130
| null | 103
| 12
| 1,550
| 2
| 1
|
no(M2 and SIP pres)
| 1
| 284
| 1
|
66.62
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 2,313
| 1,624.4463
| 1,960.05957
| null |
white
| 16.796875
| 36
| 0.887939
| 0.812988
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 3
| 115
| 11.798828
| 60
| 10
| 36.59375
| 215
| 3.099609
| null | 0.699951
| 132
| 7.449219
| 189
| 16
| 5,230
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 217
| 1
|
53.43698
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 10
|
under $11k
| 0
| 4,110
| 2,725.1269
| 2,844.35938
| 8
|
white
| 18.796875
| 21
| 0.900879
| 0.832886
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 4
| 107
| 8.798828
| 115
| 22
| 37.89844
| 218.5
| null | null | 0.599976
| 128
| 7.399414
| 116
| 4
| 2,275
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 295
| 1
|
75.01697
|
female
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 7
|
under $11k
| 0
| 27,437
| 18,642.6875
| 21,513.1875
| 24.666656
|
white
| 30.898438
| 42
| 0.633911
| 0.531982
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 18
| 72
| 0.099991
| 145
| 36
| 35.59375
| 250
| null | 0.399963
| 1.199951
| 136
| 7.439453
| 185
| 61
| 3,070
| 3
| 3
|
no(M2 and SIP pres)
| 3
| 1,074
| 0
|
37.34998
|
male
| 0
| 68
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 205,034
| 133,860.375
| 153,891.25
| 49.75
|
white
| 29
| 42
| 0.814941
| 0.75293
| 2
| 1
| 0
|
no
| null | null |
no dnr
| 68
| 62
| 14.199219
| 120
| 34
| 38.29688
| 240
| null | null | 2.299805
| 144
| 7.419922
| 308
| 83
| 4,245
| null | null | null | 3.105957
| 1,073
| 0
|
63.439
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
$11-$25k
| 0
| 23,836
| 16,231.2422
| 18,787.2188
| 27.5
|
white
| 36.796875
| 76
| 0.510986
| 0.393982
| 3
| 0
| 0
|
no
| 0.2
| 0.15
|
dnr after sadm
| 1
| 78
| 4.799805
| 80
| 6
| 36.39844
| 306.625
| null | 1.199951
| 0.599976
| 141
| 7.439453
| 148
| 7
| 6,310
| 0
| 1
|
SIP>=30
| 1
| 1,073
| 0
|
69.32794
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 11
|
under $11k
| 0
| 4,540
| 3,229.625
| 3,698.38867
| null |
white
| 13.298828
| 14
| 0.765991
| 0.516968
| 1
| 0
| 0
|
metastatic
| 0.99
| 0.95
|
no dnr
| 3
| 63
| 7.099609
| 75
| 28
| 36.09375
| null | 3.699707
| 1
| 3.199707
| 143
| null | 84
| 75
| 2,400
| 1
| 2
|
no(M2 and SIP pres)
| 2
| 411
| 1
|
59.86298
|
female
| 1
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 10
|
$25-$50k
| 9
| 37,759
| 23,176.9375
| 29,808.2188
| 51
|
white
| 46.296875
| 93
| 0.044998
| 0.014
| 1
| 0
| 0
|
metastatic
| 0.15
| 0.1
|
no dnr
| 11
| 105
| 4.899414
| 140
| 40
| 38.19531
| 176.65625
| null | 7.5
| 0.599976
| 135
| 7.489258
| 115
| 11
| 2,860
| null | 4
|
<2 mo. follow-up
| 4
| 11
| 1
|
77.45697
|
male
| 1
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
$11-$25k
| 0
| 91,649
| 56,680.8438
| 64,669.3125
| 44.25
|
white
| 35
| 77
| 0.487976
| 0.369995
| 2
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 27
| 77
| 5.399414
| 59
| 20
| 35.89844
| null | null | 0.599976
| 1.099854
| 138
| null | 80
| 15
| null | null | 0
|
<2 mo. follow-up
| 0
| 27
| 1
|
66.73798
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
|
$11-$25k
| 0
| 9,034
| 6,444.5742
| 7,167.75781
| 19
|
white
| 24.796875
| 47
| 0.795898
| 0.671997
| 1
| 0
| 0
|
no
| 0.5
| 0.2
|
no dnr
| 10
| 130
| 13.099609
| 65
| 10
| 36.5
| 356.625
| null | 0.599976
| 1.299805
| 138
| 7.339844
| 256
| 11
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 397
| 1
|
35.35699
|
male
| 0
| 17
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
>$50k
| 0
| 58,401
| 38,772.9062
| 48,513.0938
| 24
|
white
| 29.296875
| 35
| 0.519897
| 0.403992
| 16
| 0
| 0
|
yes
| 1
| 0.8
|
no dnr
| 17
| 97
| 4.799805
| 52
| 16
| 37.79688
| null | null | 0.599976
| 1.399902
| 139
| null | 103
| 19
| 3,120
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 490
| 1
|
40.94498
|
male
| 0
| 13
|
Lung Cancer
|
Cancer
| 2
| 12
|
$11-$25k
| 0
| 15,632
| 10,662.7188
| 13,903.7266
| 14
|
black
| 33.195313
| 20
| 0.360962
| 0.079987
| 1
| 0
| 0
|
metastatic
| 1
| 0.6
|
no dnr
| 13
| 79
| 14.298828
| 140
| 24
| 36.19531
| 357.125
| 2.599609
| 0.799927
| 1.899902
| 135
| 7.439453
| 182
| 24
| 1,700
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 77
| 1
|
81.38495
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 3,165
| 2,084.1113
| 2,268.95898
| 9
|
white
| 19.597656
| 25
| 0.779907
| 0.647949
| 1
| 1
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 4
| 65
| null | 105
| 10
| 37.59375
| 145
| 1.599854
| null | 3.199707
| 138
| 7.439453
| 99
| 39
| 1,105
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 283
| 1
|
80.21899
|
male
| 0
| 26
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 9
| 85,205
| 56,216.3125
| 66,549.5625
| 40
|
hispanic
| 35
| 57
| 0.110992
| 0.021999
| 10
| 1
| 0
|
no
| null | null |
dnr after sadm
| 13
| 62
| 5.799805
| 115
| 31
| 37.69531
| 142.5
| 2.099609
| 0.799927
| 0.699951
| 136
| 7.479492
| 115
| 11
| 3,090
| null | 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
64.13995
|
male
| 0
| 31
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 10
|
$25-$50k
| 9
| 73,708
| 50,837.7188
| 55,910.75
| 20
|
white
| 29.5
| 48
| 0.60498
| 0.497986
| 11
| 1
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 31
| 52
| 6.299805
| 125
| 24
| 36.19531
| null | null | 1.599854
| 1.399902
| 133
| null | 100
| 15
| 3,540
| 0
| 0
|
SIP>=30
| 0
| 435
| 1
|
41.383
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 17,069
| 10,756.2969
| 11,814.9844
| 15.5
|
white
| 20.796875
| 22
| 0.892944
| 0.85498
| 2
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 7
| 103
| 5.699219
| 120
| 24
| 36.59375
| null | 3.799805
| 0.399963
| 0.799927
| 135
| null | 120
| 4
| 925
| 5
| 4
|
SIP>=30
| 4
| 519
| 1
|
66.28595
|
male
| 1
| 8
|
Coma
|
Coma
| 3
| 18
|
under $11k
| 0
| 25,847
| 16,392.5469
| 18,955.9375
| 34.5
|
white
| 31.398438
| 55
| 0.430969
| 0.357971
| 4
| 1
| 0
|
no
| 0.05
| 0.05
|
dnr after sadm
| 5
| 127
| 20.199219
| 96
| 20
| 36.59375
| 428
| null | null | 3.599609
| 132
| 7.239258
| 132
| 87
| null | null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
54.12198
|
male
| 0
| 11
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 0
| 11,246
| 8,049.043
| 9,389.75781
| 5
|
white
| 20.5
| 36
| 0.813965
| 0.698975
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 11
| 83
| 4.599609
| 72
| 16
| 36.79688
| null | 3.899902
| 0.799927
| 1
| 137
| null | 113
| 9
| 6,000
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 278
| 1
|
60.69299
|
female
| 0
| 17
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 13
|
$11-$25k
| 100
| 35,867
| 25,898.4531
| 31,090.9219
| 18
|
black
| 16.097656
| 21
| 0.246979
| 0.143982
| 21
| 0
| 0
|
metastatic
| 0.2
| 0.1
|
dnr after sadm
| 5
| 0
| 10.199219
| 70
| 22
| 36.59375
| 142
| null | 0.799927
| 2.099609
| 133
| 7.40918
| 98
| 38
| 2,170
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 1,062
| 0
|
73.76599
|
male
| 1
| 17
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 44
| 132,628
| 85,909.3125
| 101,108.5
| 48.666657
|
white
| 35.5
| 49
| 0.014
| 0.001
| 24
| 0
| 0
|
yes
| 0.8
| 0.6
|
dnr after sadm
| 9
| 137
| 14.798828
| 59
| 12
| 36.29688
| 145
| null | null | 0.799927
| 123
| 7.479492
| 157
| 29
| 1,845
| null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
51.52399
|
female
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 18,329
| 12,042.0703
| 14,566.8984
| 14
|
white
| 17
| 20
| 0.912964
| 0.852905
| 1
| 0
| 0
|
yes
| 1
| 1
|
no dnr
| 13
| 68
| 6.099609
| 115
| 20
| 37.79688
| 324
| null | 0.799927
| 0.699951
| 137
| 7.439453
| 132
| 6
| 2,450
| 4
| 4
|
SIP>=30
| 4
| 1,060
| 0
|
74.51099
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 3
| 6
|
under $11k
| 0
| 7,807
| 5,308.9805
| 5,546.04688
| 17
|
white
| 28
| 34
| 0.576904
| 0.255981
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
dnr after sadm
| 1
| 110
| 6.899414
| 100
| 24
| 37.5
| null | null | 0.699951
| 0.699951
| 138
| null | 105
| 14
| 6,500
| 5
| 4
|
<2 mo. follow-up
| 4
| 18
| 1
|
52.58899
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 18
|
>$50k
| 0
| 50,177
| 28,641.6406
| 33,983.2812
| 35
|
white
| 22.796875
| 22
| 0.809937
| 0.745972
| 16
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 11
| 62
| 21.199219
| 70
| 27
| 36.39844
| 132
| null | 0.5
| 0.799927
| 145
| 7.5
| 228
| 27
| 1,180
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,060
| 0
|
70.21997
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 5,102
| 3,456.8359
| 4,135.29688
| 17
|
black
| 9.699219
| 16
| 0.92688
| 0.875977
| 1
| 0
| 0
|
no
| 0.98
| 0.98
|
no dnr
| 5
| 68
| 6.199219
| 125
| 30
| 36.59375
| 122.21875
| null | null | 3
| 136
| 7.319336
| 118
| 57
| 1,525
| 0
| null | null | 0.494751
| 1,059
| 0
|
74.19598
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
under $11k
| 0
| 62,839
| 35,514.8438
| 42,219.5312
| 18.666656
|
white
| 15.298828
| 17
| 0.865967
| 0.81897
| 3
| 1
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 21
| 82
| 8.798828
| 96
| 24
| 37.19531
| 314.25
| 4
| 0.599976
| 1.199951
| 141
| 7.479492
| 95
| 9
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,057
| 0
|
45.60699
|
male
| 0
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
under $11k
| 26
| 41,640
| 29,972.3125
| 32,769.6562
| 23.75
|
black
| 23.5
| 50
| 0.813965
| 0.751953
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 34
| 80
| null | 104
| 20
| 36.5
| 260
| null | 0.799927
| 1.099854
| 143
| 7.469727
| 143
| 16
| 987
| 5
| 5
|
SIP>=30
| 5
| 1,057
| 0
|
82.85797
|
female
| 1
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 8
|
under $11k
| 0
| 10,010
| 7,016.332
| 7,759.61719
| 11
|
white
| 21.699219
| 38
| 0.723999
| 0.56897
| 1
| 0
| 0
|
yes
| 0.85
| 0.6
|
no dnr
| 11
| 99
| 8.199219
| 114
| 20
| 35.79688
| null | 2.799805
| 1.099854
| 4.099609
| 136
| null | 83
| 62
| 850
| null | 2
|
<2 mo. follow-up
| 2
| 11
| 1
|
69.83398
|
female
| 1
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 14
|
$25-$50k
| 55
| 54,848
| 35,273.5625
| 40,951.875
| 49.666657
|
white
| 30.199219
| 62
| 0.350952
| 0.233978
| 5
| 0
| 0
|
no
| 0.2
| 0
|
dnr after sadm
| 12
| 127
| 13.798828
| 150
| 12
| 38.79688
| 133.3125
| 2.399902
| 1
| 1.299805
| 146
| 7.369141
| 148
| 20
| 2,645
| null | 3
|
<2 mo. follow-up
| 3
| 15
| 1
|
60.98297
|
female
| 0
| 14
|
Colon Cancer
|
Cancer
| 1
| 10
| null | 0
| 14,493
| 10,190.1797
| 13,020.5078
| 16.666656
|
white
| 26.199219
| 26
| 0.664917
| 0.362976
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.4
|
no dnr
| 14
| 132
| 16.097656
| 118
| 34
| 38.5
| 63.32812
| 2.5
| 6.199219
| 3.5
| 136
| 7.549805
| 251
| 36
| 218
| 3
| 0
|
SIP>=30
| 0
| 97
| 1
|
48.08197
|
male
| 0
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 18
|
>$50k
| 0
| 6,724
| 4,564.9688
| 5,882.49609
| 24
|
white
| 25.097656
| 30
| 0.697998
| 0.60791
| 1
| 0
| 0
|
yes
| 0.8
| 0.6
|
no dnr
| 5
| 108
| null | 70
| 20
| 35.59375
| 448
| 3.899902
| 0.5
| 3.199707
| 138
| 7.40918
| 99
| 64
| 850
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 147
| 1
|
59.81097
|
male
| 1
| 9
|
Coma
|
Coma
| 3
| 4
|
under $11k
| 26
| 78,194
| 48,746.3438
| 56,834.1562
| 57
|
hispanic
| 36
| 68
| 0.169983
| 0.11499
| 21
| 1
| 0
|
no
| 0.25
| 0.1
|
no dnr
| 9
| 105
| 20.097656
| 114
| 12
| 40.59375
| 415
| 4.299805
| 0.599976
| 2
| 147
| 7.639648
| 402
| 56
| 1,350
| null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
28.112
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 100
| 24,992
| 16,218.3984
| 18,223.0469
| 15.666664
|
white
| 22.296875
| 21
| 0.680908
| 0.587891
| 1
| 0
| 0
|
no
| 0.95
| 1
|
no dnr
| 14
| 72
| 4.799805
| 79
| 20
| 35.59375
| null | null | 0.5
| 2.299805
| 137
| null | 99
| 45
| 3,535
| null | 1
|
SIP>=30
| 1
| 1,055
| 0
|
64.85999
|
male
| 0
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 44
| 110,427
| 72,151
| 83,565.1875
| 51.5
|
white
| 21.597656
| 37
| 0.675903
| 0.581909
| 4
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 40
| 71
| 11.099609
| 106
| 6
| 36.19531
| 140
| null | null | 2.299805
| 121
| 7.419922
| 611
| 50
| 1,175
| null | 1
|
no(M2 and SIP pres)
| 1
| 1,055
| 0
|
55.38098
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 10
|
under $11k
| 0
| 6,525
| 4,105.5742
| 4,464.85938
| 11
|
white
| 22.5
| 32
| 0.879883
| 0.800903
| 1
| 1
| 0
|
no
| 0.7
| 0.4
|
no dnr
| 6
| 92
| 10.699219
| 114
| 22
| 37.09375
| 134.6875
| 3.399902
| 0.199982
| 0.899902
| 137
| 7.299805
| 152
| 35
| null | 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 106
| 1
|
62.327
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 6
| 8
|
under $11k
| 0
| 9,241
| 5,891.6875
| 6,155.33984
| 14
|
white
| 22.296875
| 47
| 0.815918
| 0.700928
| 1
| 0
| 0
|
yes
| 0.9
| 0.8
|
dnr after sadm
| 2
| 48
| 13.699219
| 147
| 28
| 38
| 240
| 1.699951
| 0.599976
| 5.199219
| 151
| 7.349609
| 104
| 102
| 2,010
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 75
| 1
|
59.03598
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 2
| 9
|
under $11k
| 0
| 5,416
| 4,056.1523
| 4,298.13672
| 7.5
|
black
| 21.097656
| 36
| 0.635986
| 0.325989
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.5
|
no dnr
| 7
| 69
| 24.097656
| 129
| 22
| 38.09375
| 115
| 2.899902
| 1.799805
| 1.199951
| 145
| 7.5
| 365
| 42
| 3,327
| 2
| 4
|
SIP>=30
| 4
| 204
| 1
|
84.53699
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 5
| null | 44
| 12,444
| 8,894.4688
| 10,864.3828
| 9.333328
|
white
| 30.5
| 53
| 0.369995
| 0.251953
| 1
| 0
| 1
|
no
| 0
| 0
|
dnr after sadm
| 1
| 103
| 8.798828
| 80
| 20
| 36.19531
| null | null | 0.399963
| 1.299805
| 131
| null | 300
| 28
| null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 79
| 1
|
44.931
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 11
|
under $11k
| 0
| 37,033
| 25,186.625
| 31,456.5469
| 46
|
hispanic
| 37.796875
| 82
| 0.448975
| 0.329956
| 22
| 1
| 0
|
yes
| null | null |
no dnr
| 5
| 60
| 13.199219
| 61
| 28
| 36.19531
| 195
| 2.599609
| 1.099854
| 0.5
| 134
| 7.359375
| 94
| 16
| 1,490
| 0
| 2
|
<2 mo. follow-up
| 2
| 5
| 1
|
72.02496
|
female
| 0
| 49
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 112,799
| 74,849.375
| 85,010.1875
| 34.25
|
white
| 16.097656
| 22
| 0.817993
| 0.756958
| 5
| 0
| 0
|
yes
| null | null |
no dnr
| 49
| 105
| 24.5
| 114
| 24
| 36.39844
| 214.8125
| 4.299805
| 0.699951
| 0.799927
| 138
| 7.429688
| 348
| 19
| 2,300
| null | null |
adl>=4 (>=5 if sur)
| 2.364746
| 735
| 1
|
50.461
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 6
|
under $11k
| 0
| 26,216
| 17,106.7031
| 19,763.375
| 31
|
hispanic
| 25.296875
| 39
| 0.79895
| 0.73291
| 6
| 1
| 0
|
no
| null | null |
no dnr
| 10
| 24
| 17.5
| 0
| 34
| 38.39844
| 77
| 3.099609
| 0.799927
| 2
| 132
| 7.359375
| 199
| 33
| 129
| null | null |
no(M2 and SIP pres)
| 3.335938
| 730
| 1
|
62.724
|
female
| 0
| 14
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
under $11k
| 0
| 19,549
| 12,885.7266
| 15,295.1328
| 22.666656
|
black
| 30.199219
| 54
| 0.554932
| 0.442993
| 1
| 0
| 0
|
yes
| 0.95
| 0.8
|
no dnr
| 14
| 71
| 13.199219
| 79
| 20
| 36.79688
| null | 2.5
| 22
| 0.699951
| 132
| null | 339
| 5
| null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 117
| 1
|
30.24199
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 9
| 41,209
| 26,259.5
| 30,153.75
| 39.666657
|
black
| 35.195313
| 41
| 0.733887
| 0.651978
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 21
| 70
| 7.199219
| 67
| 10
| 38.89844
| 222.5
| 2.299805
| 1
| 1.199951
| 133
| 7.419922
| 115
| 10
| 3,270
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 1,043
| 0
|
74.47797
|
female
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 9
| 31,667
| 21,269.9531
| 25,303
| 29.333328
|
white
| 33.398438
| 54
| 0.532959
| 0.417969
| 1
| 0
| 0
|
no
| 0.25
| 0.2
|
dnr before sadm
| 0
| 147
| 63.796875
| 157
| 34
| 40.19531
| 94
| 2.399902
| 1.299805
| 0.599976
| 134
| 7.369141
| 184
| 23
| 1,870
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 271
| 1
|
63.56198
|
female
| 0
| 14
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
$11-$25k
| 0
| 13,988
| 10,064.0312
| 12,720.2656
| 12
|
white
| 22.597656
| 10
| 0.666992
| 0.570923
| 1
| 0
| 0
|
metastatic
| 0.85
| 0.6
|
no dnr
| 14
| 61
| 19.5
| 118
| 29
| 38
| 206.65625
| 3.599609
| 0.599976
| 1.199951
| 137
| 7.449219
| 89
| 18
| 560
| 7
| 6
|
SIP>=30
| 6
| 546
| 1
|
50.05099
|
male
| 1
| 56
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 120,445
| 81,407.6875
| 96,743.5
| 35.5
|
white
| 30.898438
| 48
| 0.454956
| 0.335999
| 12
| 0
| 0
|
yes
| 0.75
| 0.6
|
dnr after sadm
| 25
| 105
| 8.099609
| 122
| 30
| 36.89844
| 132.5
| 3
| 13.398438
| 1.099854
| 137
| 7.339844
| 109
| 42
| 2,155
| 0
| 0
|
<2 mo. follow-up
| 0
| 56
| 1
|
70.60596
|
female
| 0
| 100
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
|
under $11k
| 9
| 148,396
| 98,204.875
| 117,362.125
| 38
|
black
| 32.898438
| 79
| 0.546997
| 0.43396
| 2
| 1
| 0
|
no
| 0.3
| 0.3
|
dnr after sadm
| 11
| 105
| 8.398438
| 118
| 16
| 35.59375
| 273.3125
| 3.299805
| 1.199951
| 1
| 135
| 7.459961
| 214
| 32
| 2,935
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 130
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.